Bishkek's foreign trade falls 17.6% in 5 monthsChina remains Kyrgyzstan's main trade and investment partner - Ambassador

China grants country's first COVID-19 vaccine patent to CanSino: state media

 

Фотографии: akipress.kg

August 17, 2020, 15:17       Источник akipress.kg       Комментарии

AKIPRESS.COM - China's vaccine specialist CanSino Biologics Inc has won a patent approval from Beijing for its COVID-19 vaccine candidate Ad5-nCOV, state media reported, citing documents from the country's intellectual property regulator, Reuters reported. It is the first COVID-19 vaccine patent granted by China, state-owned newspaper People's Daily reported on Sunday.
The paper cited documents published by China's National Intellectual Property Administration saying that the patent was issued on Aug. 11.
Saudi Arabia said this month it plans to begin Phase III clinical trials for the CanSino vaccine. CanSino has said it is also in talks with Russia, Brazil and Chile to launch Phase III trials in those countries.

Ссылка на новость:
https://for.kg/news-662822-en.html

Читайте также

Which country's law will Tengiz Bolturuk abide by? State Personnel Service answers

Opening of casino in Kyrgyzstan is aimed at bringing more money to the country's budget: Japarov

Kyrgyzstani athlete claims country's 7th license for Tokyo Olympics

All-women Indian pilot crew make history by completing country's longest commercial flight

Ministry of Finance wants to raise country's public debt-to-GDP threshold to 70%

 

SAPE:

 

АГРОПОРТАЛ КЫРГЫЗСТАНА, НОВОСТИ СЕЛЬСКОГО ХОЗЯЙСТВА
Обучение ювелирному делу в Бишкеке
МСН Общественно-политическая газета

18+

FOR.kg - Кыргызстан новости, пресса

FOR.kg search news service (news aggregator, media aggregator)

Read first Agreement on the use of the FOR.kg search site

When using materials from the FOR.kg - reference to the source is required

For all questions please contact customer support

Top.Mail.Ru